PM&R Journal Club

Topics: Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia:

Result from a Randomized, Double-Blind, Placebo-Controlled Trial

Speakers: Brooks W. Johnson, MD

Topics: Comparison of the Impact of Out-of-plane and In-plane Injection Approaches on Injection and Functionality in Patients with Carpal Tunnel Syndrome Undergoing Ultrasound-guided Injection:

A Patient-  and Assessor-blinded, Randomized Study

Speakers: Lester S. Duplechan, MD

Date: Wednesday,  September 10, 2025
Time: 7:00 – 8:00 am
TEAMS link sent to staff

Learning Objectives
Upon completion of this activity, participants should be able to:

1. Analyze the study design and methodology used to evaluate sublingual cyclobenzaprine in patients with fibromyalgia.
2. Interpret the efficacy outcomes and safety data of sublingual cyclobenzaprine compared with placebo.
3. Evaluate the clinical implications of sublingual cyclobenzaprine for fibromyalgia and formulate considerations for its potential integration into practice.
4. Analyze the risks and benefits of In-Plane approaches to US-guided injections.
5. Differentiate the short-term vs. long-term pain responses to carpal tunnel injection techniques.
6. Appraise the potential benefits and applicability of Out-of-Plane guided injections.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.